ICOS and neoplasm: Compared to the Treg cells in blood or adjacent normal tissue, Tregs in the tumor express higher levels of CTLA4, inducible T cell costimulator (ICOS) and tumor necrosis factor receptor superfamily member 9 (TNFRSF9; encoding 4-1BB), which reflect an activated state (32).